Results 11 to 20 of about 303,596 (194)
THERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves’ orbitopathy [PDF]
Management of Graves’ orbitopathy (GO) must be based on the correct assessment of activity and severity of the disease. Activity is usually assessed with the Clinical Activity Score, whereas severity is classified according to a European Group On Graves' Orbitopathy (EUGOGO) consensus statement as mild, moderate-to-severe, and sight-threatening ...
Irene, Campi +2 more
openaire +4 more sources
Alemtuzumab-Induced Graves' Disease Complicated by Pretibial Myxoedema: A Case Report. [PDF]
Background Alemtuzumab, a monoclonal antibody targeting CD52, is associated with a high incidence of secondary autoimmune disease, most commonly thyroid dysfunction. Alemtuzumab‐induced Graves’ disease (AIGD) typically follows a relapsing course and may exhibit atypical or severe phenotypes during immune reconstitution (IR). Case Presentation We report
O'Brolchain A, Reda E.
europepmc +2 more sources
Graves’ Orbitopathy (GO) is a localized entity of Graves’ disease, which is a challenging disease to treat. We describe 6 cases of moderate to severe GO who presented to our endocrine centre, with a mean age of 48.6 years and equal gender distribution ...
D. C. Kottahachchi +4 more
doaj +1 more source
Anti-oxidative and Anti-Adipogenic Effects of Caffeine in an in Vitro Model of Graves' Orbitopathy [PDF]
Oxidative stress and adipogenesis play key roles in the pathogenesis of Graves' orbitopathy (GO). In this study, the therapeutic effects of caffeine on the reduction of oxidative stress and adipogenesis were evaluated in primary cultured GO orbital ...
김재우, 고재상, 윤진숙
core +1 more source
World thyroidology news (#4 2015)
The article contains abstracts of actual modern international researches dedicated to management of various thyroid pathology and influence of accompanying states.
Yuliya Aleksandrovna Manuylova +2 more
doaj +1 more source
Modulating gut microbiota in a mouse model of Graves’ orbitopathy and its impact on induced disease
Background Graves’ disease (GD) is an autoimmune condition in which autoantibodies to the thyrotropin receptor (TSHR) cause hyperthyroidism. About 50% of GD patients also have Graves’ orbitopathy (GO), an intractable disease in which expansion of the ...
Sajad Moshkelgosha +18 more
doaj +1 more source
OBJECTIVE: To compare superior ophthalmic vein blood flow parameters measured with color Doppler imaging in patients with congestive Graves' orbitopathy before and after treatment and in normal controls.
Mário L. R. Monteiro +3 more
doaj +1 more source
Background: Discrepant thyroid function tests (TFTs) are typical of inappropriate secretion of TSH (IST), a rare entity encompassing TSH-secreting adenomas (TSHoma) and Resistance to Thyroid Hormone (RTHβ) due to THRB mutations.
Irene Campi +12 more
doaj +1 more source
Acute unilateral endocrine orbitopathy. A case report.
Problemstellung: Diese Arbeit beschäftigt sich mit dem Einzelfallbericht einer erwachsenen Patientin, bei welcher aufgrund eindeutiger Symptomatik eine akute einseitige endokrine Orbitopathie diagnostiziert wurde. Ausschlaggebend für diese Erkrankung war
Steinwender, Madlen
core +3 more sources
World thyroidology news (#2 2015)
The article contains abstracts of actual modern international researches dedicated to management of various thyroid pathology and influence of accompanying ...
Yu A Manuylova, M A Sviridonova
doaj +1 more source

